Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
Temporary Ovarian Suppression With Gonadotropin‐Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?The oncologist (Dayton, Ohio), 2015-11, Vol.20 (11), p.1233-1235 [Peer Reviewed Journal]2015 AlphaMed Press ;AlphaMed Press 2015 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0373 ;PMID: 26463868Full text available |
|
22 |
Material Type: Article
|
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1The oncologist (Dayton, Ohio), 2019-01, Vol.24 (1), p.103-109 [Peer Reviewed Journal]Published 2018. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0221 ;PMID: 30120163Full text available |
|
23 |
Material Type: Article
|
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis StudyThe oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1222-1231 [Peer Reviewed Journal]AlphaMed Press 2017 ;2017 The Authors The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. ;Distributed under a Creative Commons Attribution 4.0 International License ;2017 The Authors published by Wiley Periodicals, Inc. on behalf of AlphaMed Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2016-0414 ;PMID: 28550032Full text available |
|
24 |
Material Type: Article
|
Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical TrialThe oncologist (Dayton, Ohio), 2017-12, Vol.22 (12), p.1528-1534 [Peer Reviewed Journal]AlphaMed Press 2017 ;AlphaMed Press 2017. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2017-0227 ;PMID: 28894017Full text available |
|
25 |
Material Type: Article
|
Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast CancerThe oncologist (Dayton, Ohio), 2013-02, Vol.18 (2), p.123-133 [Peer Reviewed Journal]2013 AlphaMed Press ;AlphaMed Press 2013 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2012-0397 ;PMID: 23404817Full text available |
|
26 |
Material Type: Article
|
Breast Cancer, BRCA Mutations, and Attitudes Regarding Pregnancy and Preimplantation Genetic DiagnosisThe oncologist (Dayton, Ohio), 2014-08, Vol.19 (8), p.797-804 [Peer Reviewed Journal]2014 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2014 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2014-0057 ;PMID: 24951607Full text available |
|
27 |
Material Type: Article
|
A Study to Evaluate the Cause of Bone Demineralization in Gynecological Cancer SurvivorsThe oncologist (Dayton, Ohio), 2013-04, Vol.18 (4), p.423-429 [Peer Reviewed Journal]2013 AlphaMed Press ;AlphaMed Press 2013 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2012-0416 ;PMID: 23363808Full text available |
|
28 |
Material Type: Article
|
Obesity and CancerThe oncologist (Dayton, Ohio), 2010-01, Vol.15 (6), p.556-565 [Peer Reviewed Journal]2010 AlphaMed Press ;AlphaMed Press 2010 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2009-0285 ;PMID: 20507889Full text available |
|
29 |
Material Type: Article
|
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non‐Small Cell Lung Cancer With Progression On or After Platinum‐Based ChemotherapyThe oncologist (Dayton, Ohio), 2016-05, Vol.21 (5), p.634-642 [Peer Reviewed Journal]2016 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2016 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0507 ;PMID: 26984449Full text available |
|
30 |
Material Type: Article
|
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad‐Based Tumor GenotypingThe oncologist (Dayton, Ohio), 2012-01, Vol.17 (1), p.72-79 [Peer Reviewed Journal]2012 AlphaMed Press ;AlphaMed Press 2011 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2011-0386 ;PMID: 22180306Full text available |
|
31 |
Material Type: Article
|
FDG‐PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta‐Analysis of Diagnostic Accuracy StudiesThe oncologist (Dayton, Ohio), 2016-08, Vol.21 (8), p.931-939 [Peer Reviewed Journal]2016 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2016 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0353 ;PMID: 27401897Full text available |
|
32 |
Material Type: Article
|
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN StudyThe oncologist (Dayton, Ohio), 2019-02, Vol.24 (2), p.185-192 [Peer Reviewed Journal]AlphaMed Press 2018 ;AlphaMed Press 2018. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0072 ;PMID: 30190299Full text available |
|
33 |
Material Type: Article
|
Rapid Implementation of Telemedicine During the COVID‐19 Pandemic: Perspectives and Preferences of Patients with CancerThe oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.e679-e685 [Peer Reviewed Journal]2021 AlphaMed Press ;2021 AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13676 ;PMID: 33453121Full text available |
|
34 |
Material Type: Article
|
Homologous Recombination Deficiency: Cancer Predispositions and Treatment ImplicationsThe oncologist (Dayton, Ohio), 2021-09, Vol.26 (9), p.e1526-e1537 [Peer Reviewed Journal]2021 AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13829 ;PMID: 34021944Full text available |
|
35 |
Material Type: Article
|
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next‐Generation SequencingThe oncologist (Dayton, Ohio), 2014-03, Vol.19 (3), p.235-242 [Peer Reviewed Journal]2014 AlphaMed Press ;AlphaMed Press 2014 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2013-0352 ;PMID: 24563076Full text available |
|
36 |
Material Type: Article
|
Biology and Management of Patients With Triple‐Negative Breast CancerThe oncologist (Dayton, Ohio), 2016-09, Vol.21 (9), p.1050-1062 [Peer Reviewed Journal]2016 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2016 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2016-0067 ;PMID: 27401886Full text available |
|
37 |
Material Type: Article
|
Homologous Recombination Deficiency: Concepts, Definitions, and AssaysThe oncologist (Dayton, Ohio), 2022-03, Vol.27 (3), p.167-174 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyab053 ;PMID: 35274707Full text available |
|
38 |
Material Type: Article
|
FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non‐Small Cell Lung Cancer Whose Tumors Express Programmed Death‐Ligand 1The oncologist (Dayton, Ohio), 2016-05, Vol.21 (5), p.643-650 [Peer Reviewed Journal]2016 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2016 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0498 ;PMID: 27026676Full text available |
|
39 |
Material Type: Article
|
Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA TrialThe oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.e439-e450 [Peer Reviewed Journal]2019 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. ;2019 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2019-0493 ;PMID: 32162822Full text available |
|
40 |
Material Type: Article
|
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of EncephalitisThe oncologist (Dayton, Ohio), 2017-06, Vol.22 (6), p.709-718 [Peer Reviewed Journal]AlphaMed Press 2017 ;AlphaMed Press 2017. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2016-0487 ;PMID: 28495807Full text available |